Stryker Corporation Common Stock (SYK) stock analysis
SYK · Stryker Corporation Common Stock
Latest recorded price: USD 310.72
Model-estimated fair value: USD 149.07. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $310.72, SYK trades 108.4% above the model's base-case value of $149.07. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $111.29 in the conservative case and $193.03 in the optimistic case, with a valuation confidence score of 84/100. About 71% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 10.8%, free cash flow margin 17.1%, ROIC 11.3%. The model does not flag any risk signals for this company.